Soliton Inc. (NASDAQ: SOLY) Targeting Growing Tattoo-Removal, Cellulite-Reduction Industries
Soliton is positioning its proprietary technology as a new standard of care in the multimillion-dollar tattoo-removal industry The company recently filed a 501(k) with the FDA for its Rapid Acoustic Pulse tattoo-removal device Soliton’s cellulite reduction clinical trials have been featured on Yahoo Finance’s First Trade live stream Medical device company Soliton Inc. (NASDAQ: SOLY) plans to launch its Rapid Acoustic Pulse (RAP) device into the tattoo-removal market, positioning it as the new standard of care. The company also plans to complete its fat and cellulite reduction trials by 2023. The valuable new RAP technology is licensed from the University…
